Effect of High-intensity Laser Acupuncture on Muscle Performance, Pain and Quality of Life in Low Back Pain

Chronic non-specific low back pain (CNSLBP) is a persistent back pain that affects people of all ages and significantly impacts individuals' daily activities and quality of life. While various treatment modalities exist, there is ongoing interest in exploring novel approaches to manage this condition effectively. Laser photobiomodulation (PBM) therapy is a non-invasive and painless method that stimulates cells, pain receptors, and the immune system and can cause analgesic effects. In recent years, high-intensity laser has been used for managing musculoskeletal pain and dysfunction that allows for more energy deposition in deep tissues, resulting in both biological effects and thermal effects. High-intensity laser acupuncture (HILA) has emerged as a promising intervention that combines the therapeutic effects of high-intensity laser therapy and the principles of acupuncture point stimulation on the body (acupoints) to induce physiological effect. However, there is limited evidence supporting HILA efficacy in the management ofCNSLBP, with only a few studies available. For that, this study aims to investigate the effect of HILA on muscle performance, back pain, and quality of life in patients with CNSLBP. Through this current randomized controlled trial, we seek to provide evidence-based insights into the potential effects of this combined approach on measurements of muscle performance, back pain, and quality of life.

Inclusion criteria

• The patients had CNSLBP with age from 20 to 40 years from both genders.
• Patients will be referred from an orthopedist with diagnosis of chronic low back pain without underlying pathological causes.
• The patients with chronic nonspecific low back pain more than 3months. Minimum pain intensity of 30 mm on the visual analogue scale (VAS) for pain, which ranges from 0 to 100 mm.
• Patients with normal BMI ranges between 18.5:24.9 kg/m2.
• The study populations must be willing to participate in the study

Exclusion criteria

• Neurological, infectious diseases and systemic illness such as rheumatologic diseases,systemic lupus erythematosus, diabetes mellitus type I or II.
• Psychiatric/mental deficit.
• Patients who had a previous surgical history (within 6 months) will also excluded.
• participation in other treatment within the previous 3 month.
• Pregnancy.
• History of spinal fracture, tumor, osteoporosis
• use of medication, such as corticosteroids, anticonvulsants, and antiinflammatory drugs that may affect the outcome of the study.
• prior history of adverse effects to physical stimulation therapy.
• significant physical or mental deficiencies preventing a clear understanding of the study procedure.
• spinal stenosis, thyroid dysfunctions, obesity, pace-maker.